ArticleAmerican journal of translational research2025
Correlation of lung function and sarcopenia in elderly patients with chronic obstructive pulmonary disease and analysis of factors influencing sarcopenia.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Screening Utility of Lower Limb Muscle Ultrasound for Sarcopenia in COPD Patients.International journal of chronic obstructive pulmonary disease · 2026Article
- From Weight Loss to Standardized Sarcopenia Assessment: A Multi-Database Bibliometric Study of COPD with Sarcopenia (2005-2025).International journal of chronic obstructive pulmonary disease · 2026Article
- Body composition in stable COPD: associations with disease severity and early sarcopenia prediction.Frontiers in nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aims to investigate the correlation between lung function and sarcopenia in elderly patients with chronic obstructive pulmonary disease (COPD) and to analyze the factors influencing sarcopenia. The goal is to provide evidence for comprehensive management of COPD patients.
methodsA total of 294 elderly COPD patients admitted to Lanzhou City No. 1 People's Hospital from March 2022 to March 2024 were selected as study subjects. The patients were divided into a training group (n=205) and a validation group (n=89) in a 7:3 ratio. Lung function was assessed through pulmonary function tests, and sarcopenia was defined by evaluating muscle mass and muscle quality using bioelectrical impedance analysis. Based on the diagnostic criteria for sarcopenia, patients were categorized into a sarcopenia group (n=113) and a non-sarcopenia group (n=181). Basic information, lifestyle habits, and medical history were collected to analyze the correlation between lung function and sarcopenia, as well as influencing factors. Additionally, logistic regression analysis was conducted to identify independent risk factors, and a nomogram model was developed for risk prediction.
resultsMultivariate logistic regression analysis revealed that age (P<0.001, OR=0.053), weight (P=0.032, OR=3.321), Cys-C (P=0.018, OR=0.283), Hb (P=0.001, OR=7.014), FVC (P=0.04, OR=3.605), FEV1 (P=0.001, OR=9.674), and CAT score (P<0.001, OR=0.085) were independent risk factors for sarcopenia in COPD patients. The nomogram model based on these independent risk factors demonstrated good predictive performance for sarcopenia in elderly COPD patients. ROC curve analysis showed that the area under the curve (AUC) of the nomogram model was 0.886 (95% CI: 0.819-0.932) in the training group and 0.809 (95% CI: 0.726-0.883) in the validation group, indicating a high predictive accuracy. Additionally, ROC curve analysis showed that the AUCs for age, BMI, and FEV1/FVC in diagnosing sarcopenia in elderly COPD patients were 0.710 (95% CI: 0.747-0.863), 0.647 (95% CI: 0.766-0.878), and 0.682 (95% CI: 0.701-0.833), respectively. Gene Set Enrichment Analysis (GSEA) revealed that pathways significantly enriched in the high Cys-C expression group included oxidative phosphorylation, fatty acid biosynthesis, the AMPK signaling pathway, the HIF-1 signaling pathway, and glycolysis/gluconeogenesis pathways, which may play important roles in energy metabolism and muscle function regulation in sarcopenic patients.
conclusionLung function decline in elderly COPD patients is closely associated with the occurrence of sarcopenia. Increasing age is an independent risk factor for sarcopenia in COPD patients, while higher BMI and FEV1/FVC are protective factors. The nomogram model based on these independent risk factors can effectively predict sarcopenia in elderly COPD patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.